Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human Immunodeficiency Virus Type 1 Env Glycoprotein gp160 (None)
- Target
- None
- Molecular classification
- Glycoprotein, Viral protein, Envelope protein
01
Overview
The HIV-1 envelope glycoprotein gp160 is a precursor protein essential for viral entry into host cells. It is encoded by the env gene of HIV-1 and undergoes complex post-translational processing to form the mature envelope spike on the virus surface. After cleavage, it forms gp120 (responsible for receptor binding to CD4 and coreceptors CCR5 or CXCR4) and gp41 (mediates fusion between viral and cellular membranes). It is a key target for neutralizing antibodies and entry inhibitors.
- Other names
- HIV-1 Env gp160gp160Env glycoproteinEnvelope glycoprotein gp160
02
Mechanism of action
Target for neutralizing antibodies and entry inhibitors, preventing viral entry and replication.
03
Biological functions
Viral entry into host cellsReceptor bindingMembrane fusionImmune evasionAttachment
04
Disease associations
InfectionHIV-1 infectionAIDS pathogenesis
05
Safety considerations
High sequence variability leading to immune escapeExtensive glycosylation masking epitopesDevelopment of drug resistancePotential for off-target effects of inhibitors
Beyond the preview
Go deeper on Human Immunodeficiency Virus Type 1 Env Glycoprotein gp160 (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Human Immunodeficiency Virus Type 1 Env Glycoprotein gp160 (None).